ASC Communications, Inc.

Nov_Dec_2017_ASC

Issue link: https://beckershealthcare.uberflip.com/i/908020

Contents of this Issue

Navigation

Page 27 of 63

28 ORTHOPEDICS Medtronic to Study Infuse in PLF, TLIF Spine Surgeries in New Pilot Trials: 5 Things to Know By Laura Dyrda M edtronic launched new long-term clinical studies to collect prospec- tive data on posterolateral fusion and transforaminal lumbar interbody fusion proce- dures using Infuse Bone Gra. Here are five things to know: 1. Surgeons used Infuse for years to promote fusion, especially in difficult-to-fuse situations. e global study aims to expand the clinical understanding of Infuse and evaluate efficacy, safety and health economic outcomes for PLF and TLIF. 2. e prospective, multicenter, 10-year pro- gram will include 40 to 50 sites and 550 to 700 patients between a pilot and pivotal study of both procedures. e PLIF pilot dosing study already began and will include around 125 pa- tients; the TLIF dosing study will follow in 2018. 3. If the pilot studies are successful, the com- pany plans to conduct larger pivotal studies that could support peer-reviewed publications and regulatory filings. "Infuse is one of the most extensively researched biologic agents commer- cially available today and Medtronic continues to invest in research of Infuse to deepen the understanding of the benefits and risks of this novel treatment," said Medtronic Spine's Senior Vice President and President Doug King. "We're hopeful that if successful, the trials will gener- ate additional data to expand indications and provide surgeons with additional options to help alleviate pain and restore health for more patients." 4. Fort Wayne (Ind.) Orthopedics surgeons Kevin Rhan, MD, and Robert Shugart, MD, performed the first procedure in the PLF study. Infuse application for PLF and TLIF is investiga- tional only. 5. Medtronic placed Infuse on the market in 2002 and more than 1 million patients have been treated with the bone gra material. n What 15 Healthcare Organizations Pay Orthopedic Surgeons — $664k is No. 1 By Eric Oliver G lassdoor collects and compiles reported salary data. For ortho- pedic surgeons, Glassdoor says the national average salary is $444,966. Note: Ranges are used when estimated salary data can't be calculated. 1. Claxton-Hepburn Medical Center in Ogdensburg, N.Y. — $664,560 2. Trinity Regional Medical Center in Fort Dodge, Iowa — $644,899 3. Wayne County Hospital in Corydon, Iowa — $526,940 4. Physicians' Clinic of Iowa in Cedar Rapids — $507,573 5. Hays (Kan.) Medical Center — $501,284 6. Hartsville (S.C.) Medical Group — $469,241 7. Three Rivers (Mich.) Medical Clinics — $462,503 8. Millinocket (Maine) Regional Hospital — $450,778 9. Cleveland Clinic — between $638,000 and $686,000 10. Essentia Health in Duluth, Minn. — between $632,000 and $693,000 11. Kingman (Az.) Regional Medical Center — between $476,000 and 518,000 12. Mayo Clinic in Rochester, Minn. — between $446,000 and $680,000 13. Carthage (N.Y.) Area Hospital — between $405,000 and $536,000 14. Eastern Maine Medical Center in Bangor — between $351,000 and $482,000 15. Susan B. Allen Memorial Hospital in El Dorado, Kan. — $231,000 and $460,000 n Physicians Rank Top 10 Hospitals for Hip Replacements – Hospital for Special Surgery No. 1 By Mackenzie Garrity In a recent Medscape report, physicians ranked the top 10 hospitals for hip replacement. Here are the top 10 hospitals: 1. Hospital for Special Surgery – New York City 2. Mayo Clinic – Rochester, Minn. 3. Cleveland Clinic 4. Rush University Medical Center – Chicago 4. New England Baptist Hospital – Boston 4. Johns Hopkins Hosptial – Baltimore 4. Massachusetts General Hospital – Boston 8. Duke University Hospital – Durham, N.C. 8. University of California San Francisco Medical Center 8. Cedars-Sinai Medical Center – Los Angeles n

Articles in this issue

view archives of ASC Communications, Inc. - Nov_Dec_2017_ASC